Paeds Vivas · fetal-neonatal-and-perinatal
Congenital heart disease presenting in the newborn — branching viva
Branching viva from the cyanotic-versus-duct-dependent bedside split, through the day-three collapsed neonate, the positive pulse-oximetry screen, and the prostaglandin-first resuscitation and its pitfalls.
On this page & tools
Target exams
RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar covering the postnatal ward and the neonatal unit. The midwife asks you to review three newborns: a cyanotic baby found on pulse-oximetry screening, a previously well baby who has collapsed on day three, and a baby who has just started prostaglandin E1 after a positive assessment. The examiner releases information in stages.
Station opening
Examiner: "Tell me the single bedside decision that frames every newborn with suspected congenital heart disease, and why it matters." [6]
Strong candidate (must-hit)
- The decision is whether the lesion is duct-dependent: whether systemic or pulmonary blood flow can only occur through an open ductus arteriosus. It matters because the ductus closes functionally over 24 to 48 hours, so a duct-dependent baby who looks well initially will collapse — with shock (left obstruction) or cyanosis (right obstruction) — as the duct closes. Making that call early and starting prostaglandin before the echo is the difference between a planned transfer and an arrest. [6]
Weak candidate
- "We look for a murmur and do an echocardiogram." [6]
Continue reading
Paediatrics Fellowship Pro
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References7Show ledgerHide ledger
- [1]de-Wahl Granelli A; Wennergren M; Sandberg K; et al Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ, 2009.PMID 19131383
- [2]Thangaratinam S; Brown K; Zamora J; et al Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet, 2012.PMID 22554860
- [4]Mahle WT; Martin GR; Beekman RH 3rd; et al Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics, 2012.PMID 22201143
- [6]Wren C; Reinhardt Z; Khawaja K Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed, 2008.PMID 17556383
- [7]Ailes EC; Gilboa SM; Honein MA; et al Estimated number of infants detected and missed by critical congenital heart defect screening. Pediatrics, 2015.PMID 25963011
- [9]Browning Carmo KA; Barr P; West M; et al Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation. Arch Dis Child Fetal Neonatal Ed, 2007.PMID 16905574
- [10]Escobar-Diaz MC; Freud LR; Bueno A; et al Prenatal diagnosis of transposition of the great arteries over a 20-year period: improved but imperfect. Ultrasound Obstet Gynecol, 2015.PMID 25484180